Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1

International Immunopharmacology

Volumn 6, Issue 11, 2006, Pages 1690-1698

  Lin, Chiu Mei ^a,b   Chang, Hang ^c,d   Chen, Yeh Hsu ^e   Li, Shih Yun ^a   Wu, I Hsing ^b   Chiu, Jen Hwey ^a,f  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e Chung Ho Memorial Hospital   (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

IL 6; Lipopolysaccharide; VEGF; VEGFR 2; Wogonin

Indexed keywords

FLAVONOID; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 6 RECEPTOR ALPHA; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; WOGONIN;

ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; CANCER; CELL DIFFERENTIATION; CELL MIGRATION; CHORIOALLANTOIS; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; WESTERN BLOTTING;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CELL MOVEMENT; CELL SURVIVAL; CHICK EMBRYO; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FLAVANONES; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, INTERLEUKIN-6; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 33748421494     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.07.003     Document Type: Article

References (31)

1. Chi Y.S., Lim H., Park H., and Kim H.P. Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochem Pharmacol 66 (2003) 1271-1278
2. Cohen T., Nahari D., Cerem L.W., and Levi B.Z. Interleukin 6 induced the expression of vascular endothelial growth factor. J Biol Chem 271 (1996) 736-741
3. Fang J., Xia C., Cao Z., Zheng J.Z., Reed E., and Jiang B.H. Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways. FASEB J 19 (2005) 342-353
4. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25 (2004) 581-611
5. Fearon U., Griosios K., Fraser A., Reece R., Emery P., Jones P.F., et al. Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 30 (2003) 260-268
6. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1 (1995) 27-31
7. Grant D.S., Tashiro K., Segui-Real B., Yamada Y., Martin G.R., and Kleinman H.K. Two differentiations of human endothelial cells into capillary-like structures in vitro. Cell 58 (1989) 933-943
8. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., and Schaper F. Principles of interleukin (IL)-6-type cytokine signaling and its regulation. Biochem J 374 (2003) 1-20
9. Hernandez-Rodriguez J., Segarra M., Vilardell C., Sanchez M., Garcia-Martinez A., Esteban M.J., et al. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. Circulation 107 (2003) 2428-2434
10. Jeffe E.A., Nachman R.L., Becker C.G., and Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52 (1973) 2745-2756
11. Kofler S., Nickel T., and Weis M. Role of cytokines in cardiovascular disease: a focus on endothelial responses to inflammation. Clin Sci 108 (2005) 205-213
12. Kozian D.H., and Augustin H.G. Rapid identification of differentially expresses endothelial cell genes by RNA-display. Biochem Biophys Res Commun 209 (1995) 1068-1075
13. Lay I.S., Chiu J.H., Shiao M.S., Lui W.Y., and Wu C.W. Crude extract of Salvia mitiorrhiza and Salvianolic acid B enhance in vitro angiogenesis in murine SVR endothelial cell line. Planta Med 68 (2002) 1-7
14. Lin S.K., Tsai S.C., Lee C.C., Wang B.W., Liou J.Y., and Shyu K.G. Berberine inhibits HIF-1 expression via enhanced proteolysis. Mol Pharmacol 66 (2004) 612-619
15. Liu J.J., Huang T.S., Cheng W.F., and Lu F.J. Baicalein and baicalin are potent inhibitors of angiogenesis: inhibition of endothelial cell proliferation, migration and differentiation. Int J Cancer 106 (2003) 559-565
16. Lubarsky B., and Krasnow M.A. Tube morphogenesis making and shaping biological tubes. Cell 112 (2003) 19-28
17. Modur V., Li Y., Zimmerman G.A., Prescott S.M., and Mclintyre T.M. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J Clin Invest 100 (1997) 2752-2756
18. Molostvov G., Morris A., Rose P., Basu S., and Muller G. The effects of selective cytokines inhibiting drugs (CC-10004 and CC-1088) on VEGF and IL-6 expression and apoptosis in myeloma and endothelial cell co-cultures. Br J Haematol 124 (2004) 366-375
19. Morin V., Montero-Julian F.A., Gres S., Boulay V., Bongrand P., Farnarier C., et al. The IL-6, soluble IL-6Rα autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation an experimental model involving thrombin. J Immunol 167 (2001) 3435-3442
20. Nakamura N., Hayasaka S., Zhang X.Y., Nagaki Y., Matsumoto M., Hayasaka Y., et al. Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-kappa b binding activities induced by interleukin-1 beta in human retinal pigment epithelial cell line. Exp Eye Res 77 (2003) 195-202
21. Naldini A., and Carraro F. Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy 4 (2005) 3-8
22. Nicosia R.F., and Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest 63 (1990) 15-22
23. Paper D.H. Natural products as angiogenesis inhibitors. Planta Med 64 (1998) 686-695
24. Piao H.Z., Jin S.A., Chun H.S., Lee J.C., and Kim W.K. Neuroprotective effect of wogonin: potential roles of inflammatory cytokines. Arch Pharm Res 27 (2004) 930-936
25. Pollet I., Opina C.J., Zimmerman C., Leong K.G., Wong F., and Karsan A. Bacterial lipopolysaccharide directly induces Angiogenesis through TRAF6-mediated activation of NF-κB and c-Jun N-terminal kinase. Blood 102 (2003) 1740-1742
26. Ravindranath M.H., Muthugounder S., Presser N., and Viswanathan S. Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol 546 (2004) 121-165
27. Risau W. Mechanism of angiogenesis. Nature 386 (1997) 671-674
28. Salven P., Hattori K., Heissig B., and Rafii S. Interleukin-1αpromotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FESEB J 16 (2002) 1471-1473
29. Sonoda M., Nishiyama T., Matsukawa Y., and Moriyasu M. Cytotoxic activities of flavonoids from two Scutellaria plants in Chinese medicine. J Ethnopharmacol 91 (2004) 65-68
30. Unger R.E., Peters K., Huang Q., Funk A., Paul D., and Kirkpatrick C.J. Vascularization and gene regulation of human endothelial cells growing on porous polyethersulfone (PES) hollow fiber membranes. Biomaterials 26 (2005) 3461-3469
31. Yang S.H., Lin J.K., Huang C.J., Chen W.S., Li S.Y., and Chiu J.H. Silibinin inhibits angiogenesis via Flt-1, but not KDR, receptor up-regulation. J Surg Res 128 (2005) 140-146